(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
-0.22% ¥ 2 483.00
Live Chart Being Loaded With Signals
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products...
Stats | |
---|---|
Tagesvolumen | 330 900 |
Durchschnittsvolumen | 619 196 |
Marktkapitalisierung | 521.47B |
EPS | ¥0 ( 2024-02-04 ) |
Nächstes Ertragsdatum | ( ¥41.18 ) 2024-05-13 |
Last Dividend | ¥23.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 14.12 |
ATR14 | ¥1.001 (0.04%) |
Volumen Korrelation
MediPal Holdings Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
MediPal Holdings Korrelation - Währung/Rohstoff
MediPal Holdings Finanzdaten
Annual | 2022 |
Umsatz: | ¥3 360.01B |
Bruttogewinn: | ¥224.31B (6.68 %) |
EPS: | ¥184.82 |
FY | 2022 |
Umsatz: | ¥3 360.01B |
Bruttogewinn: | ¥224.31B (6.68 %) |
EPS: | ¥184.82 |
FY | 2022 |
Umsatz: | ¥3 290.92B |
Bruttogewinn: | ¥217.45B (6.61 %) |
EPS: | ¥140.14 |
FY | 2021 |
Umsatz: | ¥3 211.17B |
Bruttogewinn: | ¥214.26B (6.67 %) |
EPS: | ¥113.96 |
Financial Reports:
No articles found.
MediPal Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥23.00 (N/A) |
¥0 (N/A) |
¥23.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥6.00 | 2001-03-27 |
Last Dividend | ¥23.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 46 | -- |
Total Paid Out | ¥539.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.98 | -- |
Div. Sustainability Score | 5.56 | |
Div.Growth Potential Score | 4.59 | |
Div. Directional Score | 5.08 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8537.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7860.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7003.T | Ex Dividend Junior | 2024-03-28 | Sporadic | 0 | 0.00% | |
6356.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
5210.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
4318.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3482.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
2695.T | Ex Dividend Junior | 2023-10-30 | Annually | 0 | 0.00% | |
9065.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8151.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0106 | 1.500 | 9.79 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0199 | 1.200 | 9.34 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0646 | 1.500 | -0.393 | -0.590 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.198 | 0.800 | 9.01 | 7.21 | [1 - 3] |
quickRatioTTM | 0.928 | 0.800 | 9.25 | 7.40 | [0.8 - 2.5] |
cashRatioTTM | 0.194 | 1.500 | -0.0355 | -0.0533 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 2 432.80 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 259.54 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 259.54 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.0685 | 1.000 | -2.19 | -2.19 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0139 | 1.000 | -1.723 | -1.723 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 1.872 | 0.800 | 0.854 | 0.683 | [0.5 - 2] |
Total Score | 5.56 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 14.06 | 1.000 | 8.68 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0646 | 2.50 | -0.253 | -0.590 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 259.54 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.42 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 259.54 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.612 | 1.500 | 9.25 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0156 | 1.000 | -2.11 | 0 | [0.1 - 0.5] |
Total Score | 4.59 |
MediPal Holdings
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.